Phytochemical Sulforaphane (Dithiolthiones) and Lung diseases

Dithiolthiones are phytochemicals in the class of Organosulfides, found abundantly in cruciferous vegetables, garden sorrel, horseradish, etc.

Lung diseases is defined as a condition, affecting  the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing.
Sulforaphane may be used as a preventive chemical constituent of  pulmonary damage for patient who exposure to arsenic. According to China Medical University, arsenic-containing dust resulted in ; all of which were blocked by sulforaphane (SF) blocked pathological alterations, oxidative DNA damage, and mild apoptotic cell death in the lung caused by 2 weeks of exposure to arsenic through activation of Nrf2(master regulator of the total antioxidant system)(1). In wildtype neonatal mice exposed to hyperoxia. SF also found to activated Nrf2 activation through induced expression of anti-oxidant genes,(2). In the lungs of the arrhythmic Clock(Δ19) mice, SF also activated  it anti ovidative damage effect through activation of NRF2/glutathione defense pathway in combating oxidative/fibrotic lung damage(3).

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months

Back to 1000 free AND HEALTHY recipes and counting
http://kylejnorton.blogspot.ca/p/recipes.html

Back to Kyle J. Norton Home page http://kylejnorton.blogspot.ca      
References
(1) Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response. by Zheng Y¹, Tao S, Lian F, Chau BT, Chen J, Sun G, Fang D, Lantz RC, Zhang DD.(PubMed)
(2) Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status by McGrath-Morrow SA¹, Lauer T, Collaco JM, Lopez A, Malhotra D, Alekseyev YO, Neptune E, Wise R, Biswal S.(PubMed)
(3) The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis by Pekovic-Vaughan V¹, Gibbs J, Yoshitane H, Yang N, Pathiranage D, Guo B, Sagami A, Taguchi K, Bechtold D, Loudon A, Yamamoto M, Chan J, van der Horst GT, Fukada Y, Meng QJ.(PubMed)